UBS AM’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-278
Closed -$95.8K 2903
2019
Q3
$95.8K Buy
278
+26
+10% +$8.96K ﹤0.01% 2668
2019
Q2
$232K Buy
252
+13
+5% +$12K ﹤0.01% 2497
2019
Q1
$381K Buy
239
+15
+7% +$23.9K ﹤0.01% 2216
2018
Q4
$418K Hold
224
﹤0.01% 2065
2018
Q3
$528K Sell
224
-47
-17% -$111K ﹤0.01% 2068
2018
Q2
$934K Buy
271
+57
+27% +$196K ﹤0.01% 1834
2018
Q1
$607K Buy
214
+21
+11% +$59.5K ﹤0.01% 1950
2017
Q4
$497K Buy
193
+17
+10% +$43.8K ﹤0.01% 1976
2017
Q3
$498K Buy
+176
New +$498K ﹤0.01% 1948
2017
Q1
Sell
-1
Closed -$1K 2500
2016
Q4
$1K Sell
1
-188
-99% -$188K ﹤0.01% 2485
2016
Q3
$474K Hold
189
﹤0.01% 2011
2016
Q2
$579K Sell
189
-815
-81% -$2.5M ﹤0.01% 1888
2016
Q1
$3.19M Sell
1,004
-133
-12% -$422K ﹤0.01% 1171
2015
Q4
$5.84M Sell
1,137
-15,492
-93% -$79.5M 0.01% 1017
2015
Q3
$52.9M Sell
16,629
-14,463
-47% -$46M 0.06% 350
2015
Q2
$124M Buy
31,092
+7,032
+29% +$28.1M 0.12% 193
2015
Q1
$96.1M Sell
24,060
-2,381
-9% -$9.51M 0.09% 248
2014
Q4
$130M Sell
26,441
-458
-2% -$2.25M 0.12% 188
2014
Q3
$109M Buy
26,899
+2,253
+9% +$9.16M 0.11% 207
2014
Q2
$99.7M Buy
24,646
+2,448
+11% +$9.9M 0.1% 240
2014
Q1
$101M Sell
22,198
-3
-0% -$13.6K 0.11% 216
2013
Q4
$77.8M Buy
22,201
+1,539
+7% +$5.39M 0.09% 250
2013
Q3
$85M Buy
20,662
+125
+0.6% +$514K 0.11% 220
2013
Q2
$81.3M Buy
+20,537
New +$81.3M 0.1% 226